{"id":"https://openalex.org/W2103108681","doi":"https://doi.org/10.1001/jama.2011.860","title":"Risk of Incident Diabetes With Intensive-Dose Compared With Moderate-Dose Statin Therapy","display_name":"Risk of Incident Diabetes With Intensive-Dose Compared With Moderate-Dose Statin Therapy","publication_year":2011,"publication_date":"2011-06-21","ids":{"openalex":"https://openalex.org/W2103108681","doi":"https://doi.org/10.1001/jama.2011.860","mag":"2103108681","pmid":"https://pubmed.ncbi.nlm.nih.gov/21693744"},"language":"en","primary_location":{"id":"doi:10.1001/jama.2011.860","doi":"https://doi.org/10.1001/jama.2011.860","is_oa":false,"landing_page_url":"https://doi.org/10.1001/jama.2011.860","pdf_url":null,"source":{"id":"https://openalex.org/S172573765","display_name":"JAMA","issn_l":"0002-9955","issn":["0002-9955","0098-7484","1538-3598","2376-8118"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320259","host_organization_name":"American Medical Association","host_organization_lineage":["https://openalex.org/P4310320259"],"host_organization_lineage_names":["American Medical Association"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"JAMA","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5039985378","display_name":"David Preiss","orcid":"https://orcid.org/0000-0003-3139-1836","observed_orcids":["https://orcid.org/0000-0003-3139-1836"]},"institutions":[{"id":"https://openalex.org/I7882870","display_name":"University of Glasgow","ror":"https://ror.org/00vtgdb53","country_code":"GB","type":"education","lineage":["https://openalex.org/I7882870"]}],"countries":["GB"],"is_corresponding":true,"raw_author_name":"David Preiss","raw_affiliation_strings":["BHF Glasgow Cardiovascular Research Centre, University of Glasgow, 126 University Pl, Glasgow G12 8TA, Scotland, United Kingdom. david.preiss@glasgow.ac.uk","University of Glasgow"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"BHF Glasgow Cardiovascular Research Centre, University of Glasgow, 126 University Pl, Glasgow G12 8TA, Scotland, United Kingdom. david.preiss@glasgow.ac.uk","institution_ids":["https://openalex.org/I7882870"]},{"raw_affiliation_string":"University of Glasgow","institution_ids":["https://openalex.org/I7882870"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5039985378"],"corresponding_institution_ids":["https://openalex.org/I7882870"],"apc_list":null,"apc_paid":null,"fwci":122.8527,"has_fulltext":false,"cited_by_count":1384,"citation_normalized_percentile":{"value":0.9999171,"is_in_top_1_percent":true,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":99,"max":100},"biblio":{"volume":"305","issue":"24","first_page":"2556","last_page":"2556"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10394","display_name":"Lipoproteins and Cardiovascular Health","score":0.9976000189781189,"subfield":{"id":"https://openalex.org/subfields/2746","display_name":"Surgery"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10394","display_name":"Lipoproteins and Cardiovascular Health","score":0.9976000189781189,"subfield":{"id":"https://openalex.org/subfields/2746","display_name":"Surgery"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10027","display_name":"Diabetes, Cardiovascular Risks, and Lipoproteins","score":0.0010999999940395355,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12465","display_name":"Cancer, Lipids, and Metabolism","score":0.0007999999797903001,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/statin-therapy","display_name":"statin therapy","score":0.8230000138282776},{"id":"https://openalex.org/keywords/new-onset-diabetes","display_name":"new-onset diabetes","score":0.9570000171661377},{"id":"https://openalex.org/keywords/diabetes-risk","display_name":"diabetes risk","score":0.6340000033378601},{"id":"https://openalex.org/keywords/major-cardiovascular-events","display_name":"major cardiovascular events","score":0.8410000205039978},{"id":"https://openalex.org/keywords/cardiovascular-mortality","display_name":"cardiovascular mortality","score":0.7110000252723694},{"id":"https://openalex.org/keywords/myocardial-infarction","display_name":"myocardial infarction","score":0.8040000200271606},{"id":"https://openalex.org/keywords/stroke","display_name":"stroke","score":0.8790000081062317},{"id":"https://openalex.org/keywords/coronary-revascularization","display_name":"coronary revascularization","score":0.9319999814033508},{"id":"https://openalex.org/keywords/number-needed-to-harm","display_name":"number needed to harm","score":0.7940000295639038},{"id":"https://openalex.org/keywords/number-needed-to-treat","display_name":"number needed to treat","score":0.9160000085830688},{"id":"https://openalex.org/keywords/statin-dose-comparison","display_name":"statin dose comparison","score":0.6679999828338623},{"id":"https://openalex.org/keywords/lipid-lowering-therapy","display_name":"lipid-lowering therapy","score":0.6129999756813049},{"id":"https://openalex.org/keywords/risk-benefit-assessment","display_name":"risk-benefit assessment","score":0.5630000233650208},{"id":"https://openalex.org/keywords/hypercholesterolemia","display_name":"hypercholesterolemia","score":0.5870000123977661}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9636876583099365},{"id":"https://openalex.org/C555293320","wikidata":"https://www.wikidata.org/wiki/Q12206","display_name":"Diabetes mellitus","level":2,"score":0.6766586899757385},{"id":"https://openalex.org/C2776839432","wikidata":"https://www.wikidata.org/wiki/Q954845","display_name":"Statin","level":2,"score":0.6482606530189514},{"id":"https://openalex.org/C156957248","wikidata":"https://www.wikidata.org/wiki/Q1862216","display_name":"Odds ratio","level":2,"score":0.6385757923126221},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6162332892417908},{"id":"https://openalex.org/C44249647","wikidata":"https://www.wikidata.org/wiki/Q208498","display_name":"Confidence interval","level":2,"score":0.538700520992279},{"id":"https://openalex.org/C168563851","wikidata":"https://www.wikidata.org/wiki/Q1436668","display_name":"Randomized controlled trial","level":2,"score":0.5335619449615479},{"id":"https://openalex.org/C500558357","wikidata":"https://www.wikidata.org/wiki/Q12152","display_name":"Myocardial infarction","level":2,"score":0.5139076709747314},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.05357414484024048}],"mesh":[{"descriptor_ui":"D002318","descriptor_name":"Cardiovascular Diseases","qualifier_ui":"Q000453","qualifier_name":"epidemiology","is_major_topic":false},{"descriptor_ui":"D002318","descriptor_name":"Cardiovascular Diseases","qualifier_ui":"Q000517","qualifier_name":"prevention & control","is_major_topic":true},{"descriptor_ui":"D003920","descriptor_name":"Diabetes Mellitus","qualifier_ui":"Q000453","qualifier_name":"epidemiology","is_major_topic":true},{"descriptor_ui":"D004305","descriptor_name":"Dose-Response Relationship, Drug","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012306","descriptor_name":"Risk","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016017","descriptor_name":"Odds Ratio","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016032","descriptor_name":"Randomized Controlled Trials as Topic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D019161","descriptor_name":"Hydroxymethylglutaryl-CoA Reductase Inhibitors","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D019161","descriptor_name":"Hydroxymethylglutaryl-CoA Reductase Inhibitors","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true}],"locations_count":7,"locations":[{"id":"doi:10.1001/jama.2011.860","doi":"https://doi.org/10.1001/jama.2011.860","is_oa":false,"landing_page_url":"https://doi.org/10.1001/jama.2011.860","pdf_url":null,"source":{"id":"https://openalex.org/S172573765","display_name":"JAMA","issn_l":"0002-9955","issn":["0002-9955","0098-7484","1538-3598","2376-8118"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320259","host_organization_name":"American Medical Association","host_organization_lineage":["https://openalex.org/P4310320259"],"host_organization_lineage_names":["American Medical Association"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"JAMA","raw_type":"journal-article"},{"id":"pmid:21693744","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/21693744","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"JAMA","raw_type":"Journal Article"},{"id":"pmh:oai:pure.amsterdamumc.nl:openaire_cris_publications/4b2d17c8-e1d6-41ba-bc2b-534c66021819","doi":null,"is_oa":false,"landing_page_url":"https://pure.amsterdamumc.nl/en/publications/4b2d17c8-e1d6-41ba-bc2b-534c66021819","pdf_url":null,"source":{"id":"https://openalex.org/S7407055222","display_name":"Pure Amsterdam UMC","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Preiss, D, Seshasai, S R K, Welsh, P, Murphy, S A, Ho, J E, Waters, D D, Demicco, D A, Barter, P, Cannon, C P, Sabatine, M S, Braunwald, E, Kastelein, J J P, de Lemos, J A, Blazing, M A, Pedersen, T R, Tikkanen, M J, Sattar, N & Ray, K K 2011, 'Risk of Incident Diabetes With Intensive-Dose Compared With Moderate-Dose Statin Therapy A Meta-analysis', JAMA, vol. 305, no. 24, pp. 2556-2564. https://doi.org/10.1001/jama.2011.860","raw_type":"info:eu-repo/semantics/review"},{"id":"pmh:amcpub:oai:pure.amc.nl:publications/d51f3a34-c5f9-41fa-97ef-6265aa394c46","doi":null,"is_oa":false,"landing_page_url":"https://pure.amc.nl/en/publications/risk-of-incident-diabetes-with-intensivedose-compared-with-moderatedose-statin-therapy-a-metaanalysis(d51f3a34-c5f9-41fa-97ef-6265aa394c46).html","pdf_url":null,"source":{"id":"https://openalex.org/S4306401843","display_name":"Data Archiving and Networked Services (DANS)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1322597698","host_organization_name":"Royal Netherlands Academy of Arts and Sciences","host_organization_lineage":["https://openalex.org/I1322597698"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"JAMA, 305(24), 2556 - 2564. American Medical Association","raw_type":"info:eu-repo/semantics/other"},{"id":"pmh:oai:eprints.gla.ac.uk:53938","doi":null,"is_oa":false,"landing_page_url":"http://eprints.gla.ac.uk/53938/","pdf_url":null,"source":{"id":"https://openalex.org/S4210235606","display_name":"ENLIGHTEN (Jurnal Bimbingan dan Konseling Islam)","issn_l":"2622-8912","issn":["2622-8912","2622-8920"],"is_oa":false,"is_in_doaj":true,"is_core":false,"listed_in":["doaj"],"host_organization":"https://openalex.org/I4405259220","host_organization_name":"Institut Agama Islam Negeri Langsa","host_organization_lineage":["https://openalex.org/I4405259220"],"host_organization_lineage_names":[],"type":"journal"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"Articles"},{"id":"pmh:oai:spiral.imperial.ac.uk:10044/1/39305","doi":null,"is_oa":false,"landing_page_url":"http://hdl.handle.net/10044/1/39305","pdf_url":null,"source":{"id":"https://openalex.org/S4306401396","display_name":"Spiral (Imperial College London)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I47508984","host_organization_name":"Imperial College London","host_organization_lineage":["https://openalex.org/I47508984"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"2556","raw_type":"Journal Article"},{"id":"mag:2326757113","doi":null,"is_oa":false,"landing_page_url":"https://www.natap.org/2011/HIV/JAMAPreiss255664.pdf","pdf_url":null,"source":null,"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":1.0}],"study_designs":[{"display_name":"Systematic Review","id":"https://openalex.org/study-designs/systematic-review"},{"display_name":"Meta-Analysis","id":"https://openalex.org/study-designs/meta-analysis"}],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":40,"referenced_works":["https://openalex.org/W29474508","https://openalex.org/W137344628","https://openalex.org/W146577346","https://openalex.org/W1523152575","https://openalex.org/W1553537184","https://openalex.org/W1570093475","https://openalex.org/W1660053632","https://openalex.org/W1968240228","https://openalex.org/W1996242285","https://openalex.org/W1998391689","https://openalex.org/W2018711158","https://openalex.org/W2040462758","https://openalex.org/W2052703897","https://openalex.org/W2061489988","https://openalex.org/W2097870088","https://openalex.org/W2100800328","https://openalex.org/W2112706810","https://openalex.org/W2115169717","https://openalex.org/W2125435699","https://openalex.org/W2127603048","https://openalex.org/W2131377217","https://openalex.org/W2137489898","https://openalex.org/W2139168645","https://openalex.org/W2150144996","https://openalex.org/W2154704322","https://openalex.org/W2156098321","https://openalex.org/W2159449551","https://openalex.org/W2164089346","https://openalex.org/W2166910397","https://openalex.org/W2219384223","https://openalex.org/W2247997571","https://openalex.org/W2317295570","https://openalex.org/W2324263709","https://openalex.org/W2332947453","https://openalex.org/W2468996569","https://openalex.org/W2991792334","https://openalex.org/W2993710980","https://openalex.org/W4234911170","https://openalex.org/W4243284365","https://openalex.org/W4245466177"],"related_works":["https://openalex.org/W2330630641","https://openalex.org/W2206175373","https://openalex.org/W2067922796","https://openalex.org/W2020043339","https://openalex.org/W2115169717","https://openalex.org/W4387674133","https://openalex.org/W7096715413","https://openalex.org/W1987579115","https://openalex.org/W7098149066","https://openalex.org/W4401825303"],"abstract_inverted_index":{"CONTEXT:":[0],"A":[1],"recent":[2],"meta-analysis":[3],"demonstrated":[4],"that":[5,79],"statin":[6,22,35,82,86,165,265,276,293,309,312,326],"therapy":[7,23,83,87,256,277,294,313],"is":[8,24],"associated":[9,25,315],"with":[10,26,33,84,167,258,263,316,324],"excess":[11],"risk":[12,28,319],"of":[13,29,47,55,116,222,305,320],"developing":[14,118],"diabetes":[15,31,119,142,171,176,240,282,322],"mellitus.":[16],"OBJECTIVE:":[17],"To":[18],"investigate":[19],"whether":[20],"intensive-dose":[21,81,179,191,211,275,292,311],"increased":[27,318],"new-onset":[30,141,239,281,321],"compared":[32,80,257,262,323],"moderate-dose":[34,85,183,259,264,325],"therapy.":[36,260,327],"DATA":[37,103],"SOURCES:":[38],"We":[39,73,134],"identified":[40],"relevant":[41],"trials":[42,78,166],"in":[43,189,209],"a":[44,217,302],"literature":[45],"search":[46],"MEDLINE,":[48],"EMBASE,":[49],"and":[50,88,114,120,143,147,196,202,241],"the":[51,159,190,210,267,284],"Cochrane":[52],"Central":[53],"Register":[54],"Controlled":[56],"Trials":[57],"(January":[58],"1,":[59],"1996,":[60],"through":[61],"March":[62],"31,":[63],"2011).":[64],"Unpublished":[65],"data":[66,106,306],"were":[67,95,228],"obtained":[68],"from":[69,307],"investigators.":[70],"STUDY":[71],"SELECTION:":[72],"included":[74,89],"randomized":[75],"controlled":[76],"end-point":[77],"more":[90,99],"than":[91,100],"1000":[92,194,214],"participants":[93,117,169,253],"who":[94],"followed":[96],"up":[97],"for":[98,108,140,238,249,252,274,280,291,297],"1":[101],"year.":[102],"EXTRACTION:":[104],"Tabular":[105],"provided":[107],"each":[109],"trial":[110],"described":[111],"baseline":[112],"characteristics":[113],"numbers":[115],"experiencing":[121],"major":[122,144],"cardiovascular":[123,145,199,250,298],"events":[124,146,200,251],"(cardiovascular":[125],"death,":[126],"nonfatal":[127],"myocardial":[128],"infarction":[129],"or":[130],"stroke,":[131],"coronary":[132],"revascularization).":[133],"calculated":[135],"trial-specific":[136],"odds":[137],"ratios":[138,227],"(ORs)":[139],"combined":[148],"these":[149],"using":[150,158],"random-effects":[151],"model":[152],"meta-analysis.":[153],"Between-study":[154],"heterogeneity":[155],"was":[156,278,295,314],"assessed":[157],"I(2)":[160,235,246],"statistic.":[161],"RESULTS:":[162],"In":[163,301],"5":[164,308],"32,752":[168],"without":[170],"at":[172],"baseline,":[173],"2749":[174],"developed":[175],"(1449":[177],"assigned":[178,182],"therapy,":[180,184,266],"1300":[181],"representing":[185,205],"2.0":[186],"additional":[187],"cases":[188,208],"group":[192,212],"per":[193,213,272,289],"patient-years)":[195,215],"6684":[197],"experienced":[198],"(3134":[201],"3550,":[203],"respectively,":[204],"6.5":[206],"fewer":[207],"over":[216],"weighted":[218],"mean":[219],"(SD)":[220],"follow-up":[221],"4.9":[223],"(1.9)":[224],"years.":[225],"Odds":[226],"1.12":[229],"(95%":[230,243],"confidence":[231],"interval":[232],"[CI],":[233],"1.04-1.22;":[234],"=":[236,247],"0%)":[237],"0.84":[242],"CI,":[244],"0.75-0.94;":[245],"74%)":[248],"receiving":[254],"intensive":[255],"As":[261],"number":[268,285],"needed":[269,286],"to":[270,287],"harm":[271],"year":[273,290],"498":[279],"while":[283],"treat":[288],"155":[296],"events.":[299],"CONCLUSION:":[300],"pooled":[303],"analysis":[304],"trials,":[310],"an":[317]},"counts_by_year":[{"year":2026,"cited_by_count":39},{"year":2025,"cited_by_count":27},{"year":2024,"cited_by_count":66},{"year":2023,"cited_by_count":72},{"year":2022,"cited_by_count":82},{"year":2021,"cited_by_count":55},{"year":2020,"cited_by_count":71},{"year":2019,"cited_by_count":96},{"year":2018,"cited_by_count":100},{"year":2017,"cited_by_count":92},{"year":2016,"cited_by_count":135},{"year":2015,"cited_by_count":152},{"year":2014,"cited_by_count":144},{"year":2013,"cited_by_count":129},{"year":2012,"cited_by_count":87}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}